However, after the degradation of HO-1-mediated heme, the release of Fe2+ shows a pro-oxidative effect and cytotoxicity (29), may aggravate the in situ hemolysis and shorten the RBC lifespan in MDS patients.These inflammatory cytokines were decreased significantly after ICT. The gene discussed is HMOX1; the disease is myelodysplastic syndrome.